Cullinan Therapeutics, Inc. (CGEM)
NASDAQ·Healthcare·Biotechnology
$17.37
-19.84%
Mkt Cap $1.30B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (16 analysts)
$31.25
Range $28.00 – $37.00
Implied Upside
+79.9%
Consensus $31.25 vs current $17.37
NASDAQ·Healthcare·Biotechnology
$17.37
-19.84%
Mkt Cap $1.30B
Buy
11
Hold
0
Sell
0
Price Target (16 analysts)
$31.25
Range $28.00 – $37.00
+79.9%
Consensus $31.25 vs current $17.37